ESMO Open, 2025 First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors Naing A., McKean M., Rosen L. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Gut, 2025 Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deterioration Hardy M., Russell A., Henneken L. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
European Journal of Nutrition, 2025 Association between ultra-processed food consumption and inflammation: insights from the STANISLAS cohort Xia L., Girerd N., Lamiral Z. et al. Olink Target 96Nutritional SciencePathophysiologyPlasma | | | | |
Scientific Reports, 2025 Biomarkers of inflammation in sweat after myocardial infarction Björkenheim A., Sunnefeldt E., Finke K. et al. Olink Target 96CVDTechnical EvaluationPlasmaSweat | | | | |
Aging Cell, 2025 Healthy Aging Metabolomic and Proteomic Signatures Across Multiple Physiological Compartments Moaddel R., Candia J., Ubaida‐Mohien C. et al. Olink Explore 3072/384AgingPathophysiologyPlasmaUrine | | | | |
Translational Psychiatry, 2025 Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia Yee J., Phua S., See Y. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
The Journal of Clinical Endocrinology & Metabolism, 2025 Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes Gurung R., Zheng H., Tan J. et al. Olink Explore 3072/384Metabolic DiseasesNephrologyPathophysiologyPlasma | | | | |
Nature, 2025 Genetic architecture in Greenland is shaped by demography, structure and selection Stæger F., Andersen M., Li Z. et al. Olink Target 96Wider Proteomics StudiesPathophysiologyPlasma | | | | |
Cytokine, 2025 A pilot investigation on inflammatory markers and theta burst stimulation protocol interaction along a three-month recovery course following an isolated upper limb fracture Robitaille B., Herrero Babiloni A., Jodoin M. et al. Olink Explore 3072/384Other Diseases & SyndromesPathophysiologySerum | | | | |
European Journal of Nutrition, 2025 Plant-based dietary patterns, genetic risk, proteome, and lung cancer risk: a large prospective cohort study Zhu W., Shi Z., Yan X. et al. Olink Explore 3072/384OncologyNutritional SciencePathophysiologyPlasma | | | | |
Children, 2025 Novel Inflammatory Biomarkers for Autism Spectrum Disorder Detected by Plasma Olink Proteomics Lv T., Wang M., Kui L. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
eBioMedicine, 2025 Linking obesity-associated genotype to child language development: the role of early-life neurology-related proteomics and brain myelination Huang J., Che J., Kee M. et al. Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPlasma | | | | |
PROTEOMICS, 2025 Comparative Analysis Between Olink‐PEA and Alamar‐NULISA Proteomic Technologies Applied to a Critically Ill COVID‐19 Cohort Taleb S., Stephan N., Chennakkandathil S. et al. Olink Target 96Wider Proteomics StudiesInfectious DiseasesTechnology EvaluationCross-platform ValidationPlasma | | | | |
Pediatric Research, 2025 Gut microbiota, inflammatory cytokines, and Kawasaki disease: a Mendelian randomization study and mediation analysis Wang J., Dou H., Liang Q. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Nature Genetics, 2025 Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups Hoffmann T., Graff R., Madduri R. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Frontiers in Endocrinology, 2025 Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid Wang C., Feng Y., Chen Y. et al. Olink Target 96ObstetricsPatient StratificationSerumFollicular Fluid | | | | |
Brain Communications, 2025 An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis van Eijk R., Steyn F., Janse van Mantgem M. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Arthritis Research & Therapy, 2025 Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype Xu X., Qiu T., Sun K. et al. Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
International Journal of Chronic Obstructive Pulmonary Disease, 2025 The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD Yan K., Wang Y., Xin P. Olink Target 96Respiratory DiseasesPathophysiologyPlasma | | | | |
Movement Disorders, 2025 Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [11C]PBR28 PET Wallin J., Forsberg A., Svenningsson P. Olink Target 96NeurologyPathophysiologyPlasmaCSF | | | | |